A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial

Sunil S Solomon, Sandra Wagner-Cardoso, Laura Smeaton, Leonard A Sowah, Chanelle Wimbish, Gregory Robbins, Irena Brates, Christine Scello, Annie Son, Anchalee Avihingsanon, Benjamin Linas, Donald Anthony, Estevão Portela Nunes, Dimas A Kliemann, Khuanchai Supparatpinyo, Cissy Kityo, Pablo Tebas, Jaclyn Ann Bennet, Jorge Santana-Bagur, Constance A Benson, Marije Van Schalkwyk, Nelson Cheinquer, Susanna Naggie, David Wyles, Mark Sulkowski

Open source

DOI
10.1016/s2468-1253(21)00397-6
Published
2022-04
Container
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-21-00397-6,
  title = {A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial},
  author = {Sunil S Solomon and Sandra Wagner-Cardoso and Laura Smeaton and Leonard A Sowah and Chanelle Wimbish and Gregory Robbins and Irena Brates and Christine Scello and Annie Son and Anchalee Avihingsanon and Benjamin Linas and Donald Anthony and Estevão Portela Nunes and Dimas A Kliemann and Khuanchai Supparatpinyo and Cissy Kityo and Pablo Tebas and Jaclyn Ann Bennet and Jorge Santana-Bagur and Constance A Benson and Marije Van Schalkwyk and Nelson Cheinquer and Susanna Naggie and David Wyles and Mark Sulkowski},
  year = {2022},
  journal = {The Lancet Gastroenterology \& Hepatology},
  doi = {10.1016/s2468-1253(21)00397-6},
  url = {https://doi.org/10.1016/s2468-1253(21)00397-6}
}

RIS

TY  - JOUR
TI  - A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial
AU  - Sunil S Solomon
AU  - Sandra Wagner-Cardoso
AU  - Laura Smeaton
AU  - Leonard A Sowah
AU  - Chanelle Wimbish
AU  - Gregory Robbins
AU  - Irena Brates
AU  - Christine Scello
AU  - Annie Son
AU  - Anchalee Avihingsanon
AU  - Benjamin Linas
AU  - Donald Anthony
AU  - Estevão Portela Nunes
AU  - Dimas A Kliemann
AU  - Khuanchai Supparatpinyo
AU  - Cissy Kityo
AU  - Pablo Tebas
AU  - Jaclyn Ann Bennet
AU  - Jorge Santana-Bagur
AU  - Constance A Benson
AU  - Marije Van Schalkwyk
AU  - Nelson Cheinquer
AU  - Susanna Naggie
AU  - David Wyles
AU  - Mark Sulkowski
PY  - 2022
JO  - The Lancet Gastroenterology & Hepatology
DO  - 10.1016/s2468-1253(21)00397-6
UR  - https://doi.org/10.1016/s2468-1253(21)00397-6
ER  - 

APA

Solomon, S. S., Wagner-Cardoso, S., Smeaton, L., Sowah, L. A., Wimbish, C., Robbins, G., Brates, I., Scello, C., Son, A., Avihingsanon, A., Linas, B., Anthony, D., Nunes, E. P., Kliemann, D. A., Supparatpinyo, K., Kityo, C., Tebas, P., Bennet, J. A., Santana-Bagur, J., Benson, C. A., Schalkwyk, M. V., Cheinquer, N., Naggie, S., Wyles, D., & Sulkowski, M. (2022). A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(21)00397-6

Source records